desoxycorticosterone has been researched along with transforming growth factor beta in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Kim, S; Miura, K; Ohta, K; Omura, T; Wada, T; Yukimura, T | 1 |
| Franco-Saenz, R; Gupta, P; Mulrow, PJ | 1 |
| Dohmen, S; Matsumura, Y; Mitsutomi, N; Morimoto, S; Takada, K; Takaoka, M | 1 |
| Border, WA; Noble, NA | 1 |
| Ammarguellat, F; Larouche, I; Schiffrin, EL | 1 |
| Kangawa, K; Kobayashi, N; Matsuoka, H; Mori, Y; Nishikimi, T; Ono, H | 1 |
| Kobayashi, N; Matsuoka, H; Mita, S; Tsubokou, Y; Yoshida, K | 1 |
| Frei, U; Jürgensen, JS; Noack, K; Qun, Y; Schindler, R; Tanriver, Y; Tullius, SG | 1 |
| Hirade, S; Inoue, H; Kagitani, S; Takahashi, T; Takata, M; Ueno, H | 1 |
| Bledsoe, G; Chao, J; Chao, L; Xia, CF | 1 |
| Aicher, WK; Alexander, D; Artunc, F; Friedrich, B; Janessa, A; Lang, F; Müller, GA; Risler, T | 1 |
| Jadhav, A; Ndisang, JF | 1 |
| Kobara, M; Kojima, Y; Nakano, A; Nakata, T; Noda, K; Oshima, Y; Toba, H; Tojo, C; Wang, J; Yoshida, M | 1 |
| Wang, DH; Wang, Y | 1 |
1 review(s) available for desoxycorticosterone and transforming growth factor beta
| Article | Year |
|---|---|
TGF-beta in kidney fibrosis: a target for gene therapy.
Topics: Animals; Desoxycorticosterone; Diabetic Nephropathies; Fibrosis; Genetic Therapy; Glomerulonephritis; Graft Rejection; Humans; Kidney; Kidney Transplantation; Transforming Growth Factor beta | 1997 |
13 other study(ies) available for desoxycorticosterone and transforming growth factor beta
| Article | Year |
|---|---|
Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Desoxycorticosterone; Enalapril; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Rats; Rats, Wistar; Renin; RNA, Messenger; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta | 1994 |
Transforming growth factor-beta 1 inhibits aldosterone biosynthesis in cultured bovine zona glomerulosa cells.
Topics: Aldosterone; Angiotensin II; Animals; Cattle; Cell Survival; Cells, Cultured; Corticosterone; Desoxycorticosterone; Kinetics; Mineralocorticoid Receptor Antagonists; Potassium; Pregnenolone; Transforming Growth Factor beta; Zona Glomerulosa | 1993 |
Endothelin-1 secretion from cultured vascular endothelial cells of DOCA-salt hypertensive rats.
Topics: Animals; Aorta; Cells, Cultured; Desoxycorticosterone; Endothelins; Endothelium, Vascular; Hypertension; Kinetics; Male; Nitro Compounds; Rats; Rats, Sprague-Dawley; Reference Values; Sodium Chloride; Thrombin; Transforming Growth Factor beta; Vasodilator Agents | 1996 |
Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Topics: Animals; Atrasentan; Blood Pressure; Collagen; Collagen Type I; Desoxycorticosterone; Endothelin A Receptor Antagonists; Fibrosis; Hypertension; Male; Myocardium; Organ Size; Pyrrolidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Long-term adrenomedullin infusion improves survival in malignant hypertensive rats.
Topics: Adrenomedullin; Aldosterone; Angiotensin II; Animals; Blood Pressure; Body Weight; Desoxycorticosterone; Heart Rate; Humans; Hypertension, Malignant; Infusion Pumps; Injections, Subcutaneous; Kidney; Male; Organ Size; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; RNA, Messenger; Survival Rate; Time Factors; Transforming Growth Factor beta; Vasodilator Agents | 2002 |
Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats.
Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Body Weight; Celiprolol; Desoxycorticosterone; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Hypertension; Male; Mitogen-Activated Protein Kinases; Organ Size; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2002 |
Hypertension increases expression of growth factors and MHC II in chronic allograft nephropathy.
Topics: Animals; Blood Pressure; Chronic Disease; Desoxycorticosterone; Gene Expression; Graft Rejection; Histocompatibility Antigens Class II; Hypertension, Renal; Kidney Transplantation; Male; Proto-Oncogene Proteins c-sis; Rats; Rats, Inbred F344; Rats, Inbred Lew; RNA, Messenger; Transforming Growth Factor beta; Transplantation, Homologous | 2003 |
Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Weight; Cardiomegaly; Chemokine CCL2; Collagen Type I; Collagen Type III; Desoxycorticosterone; Fibrosis; Hypertension; Interleukin-6; Macrophages; Male; Monocytes; Myocardium; Nephrectomy; Organ Size; ortho-Aminobenzoates; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride, Dietary; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats.
Topics: Animals; Cell Cycle Proteins; Cell Division; Cyclic GMP; Cyclin-Dependent Kinase Inhibitor p27; Desoxycorticosterone; Disease Models, Animal; Extracellular Matrix; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Transfer Techniques; Genetic Therapy; Hypertension, Renal; Hypertrophy; JNK Mitogen-Activated Protein Kinases; Kallikreins; Male; Nitrates; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Sodium Chloride, Dietary; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Suppressor Proteins | 2005 |
DOCA and TGF-beta induce early growth response gene-1 (Egr-1) expression.
Topics: Animals; Cell Line; Desoxycorticosterone; Disease Models, Animal; Early Growth Response Protein 1; Fibrosis; Gene Expression Regulation; Humans; Kidney Diseases; Mice; Sodium Chloride; Time Factors; Transfection; Transforming Growth Factor beta | 2008 |
Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension.
Topics: Animals; Arginine; Cardiomegaly; Desoxycorticosterone; Disease Models, Animal; Heart; Heart Diseases; Heme; Heme Oxygenase (Decyclizing); Hypertension; Hypertrophy, Left Ventricular; Male; MAP Kinase Kinase 4; Mesoporphyrins; Myocardium; NF-kappa B; Rats; Rats, Sprague-Dawley; Transcription Factor AP-1; Transforming Growth Factor beta | 2009 |
L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Collagen; Desoxycorticosterone; Dihydropyridines; Disease Models, Animal; Hypertension; Intracellular Signaling Peptides and Proteins; Kidney; Male; Membrane Proteins; Proteinuria; Rats; Rats, Wistar; Renin-Angiotensin System; Sodium Chloride; Transforming Growth Factor beta; Treatment Outcome | 2011 |
Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Fibronectins; Fibrosis; Heart Rate; Hypertension; Kidney; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Mice; Phosphorylation; Protective Agents; Signal Transduction; Smad Proteins; Smad2 Protein; Smad3 Protein; Time Factors; Transforming Growth Factor beta; TRPV Cation Channels | 2011 |